8-K
Current Report
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001193125-18-330256
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d655434d8k.htm…